Arkolith/Insider Trading/IMVT/Form 4

Fromkin Andrew J.

DirectorImmunovant, Inc. (IMVT) · full profile →Form 4 · filed May 29, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$7.4M
Net Open-Market Flow
-$7.4M
Transactions
10
6 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 28, 2026Option exercise(M)32K$4.99$158K131K
May 28, 2026Option exercise(M)71K$7.94$568K203K
May 28, 2026Option exercise(M)77K$8.43$651K280K
May 28, 2026Option exercise(M)16K$14.70$239K296K
May 28, 2026Sell(S)11K$32.64$375K285K
May 28, 2026Sell(S)210K$33.56$7.1M74K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 28, 2026Option exercise(M)32K—$00
May 28, 2026Option exercise(M)71K—$00
May 28, 2026Option exercise(M)77K—$00
May 28, 2026Option exercise(M)16K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001341896-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML